Mount Scopus

Israeli companies present breakthrough medical technologies - IMPROVATE Life-Saving Technologies Conference: Cell therapies, bio-engineering, big-data analytics creating future of medicine

Retrieved on: 
Thursday, July 29, 2021
Zionism, Hadassah Medical Center, Hadassah Women's Zionist Organization of America, Hebrew University of Jerusalem, Mount Scopus

Prof. Ze'ev Rotstein, Director of Hadassah Medical Center, addressed the conference on how better data creates better care.

Key Points: 
  • Prof. Ze'ev Rotstein, Director of Hadassah Medical Center, addressed the conference on how better data creates better care.
  • Big data is not only the clinical data of the patients, but we are deepening our understanding of all the genomics.
  • Former Bulgarian President and IMPROVATE advisory board member Rosen Plevneliev said the European market holds huge opportunities for Israeli companies.
  • IMedishas developed Duali-Q, a revolutionary medical innovation that promotes early detection of cancer and other life-threatening diseases using AI technology.

Israeli companies present breakthrough medical technologies - IMPROVATE Life-Saving Technologies Conference: Cell therapies, bio-engineering, big-data analytics creating future of medicine

Retrieved on: 
Thursday, July 29, 2021
Zionism, Hadassah Medical Center, Hadassah Women's Zionist Organization of America, Hebrew University of Jerusalem, Mount Scopus

Prof. Ze'ev Rotstein, Director of Hadassah Medical Center, addressed the conference on how better data creates better care.

Key Points: 
  • Prof. Ze'ev Rotstein, Director of Hadassah Medical Center, addressed the conference on how better data creates better care.
  • Big data is not only the clinical data of the patients, but we are deepening our understanding of all the genomics.
  • Former Bulgarian President and IMPROVATE advisory board member Rosen Plevneliev said the European market holds huge opportunities for Israeli companies.
  • IMedishas developed Duali-Q, a revolutionary medical innovation that promotes early detection of cancer and other life-threatening diseases using AI technology.

Yissum Spinouts Raise $79 million in H1 2020 Despite Coronavirus Uncertainty

Retrieved on: 
Tuesday, July 28, 2020
Geography of Asia, Geography of religion, Cities in Asia, Hebrew University of Jerusalem, Mount Scopus, Jérusalem, Nectin, Yissum Research Development Company of the Hebrew University

JERUSALEM, July 28, 2020 /PRNewswire/ --Startups from The Hebrew University of Jerusalem raised $79 million in the first half of 2020, Yissum, the technology transfer company of the Hebrew University announced today.

Key Points: 
  • JERUSALEM, July 28, 2020 /PRNewswire/ --Startups from The Hebrew University of Jerusalem raised $79 million in the first half of 2020, Yissum, the technology transfer company of the Hebrew University announced today.
  • Despite the continuing global uncertainty caused by the coronavirus and ongoing lockdowns around the world, 14 Yissum spinouts raised tens of millions of dollars in early stage funding rounds.
  • Investments were made in companies in the cleantech, agriculture and foodtech sectors as well as in life science, AI and education.
  • Yissum spinouts that raised funds during in the first half of 2020 include Tissue Dynamics, an AI organ-on-chip drug development company, and Nectin Therapeutics, an immune-oncology biotech focused on cancer therapies.

Hebrew University Researchers Submit Proposals to Israel Innovation Authority to Investigate Diagnostics, Treatments, and Cures for Covid-19

Retrieved on: 
Thursday, March 26, 2020
Business, Articles, Economy, Hebrew University of Jerusalem, Mount Scopus, Medtech, Coronavirus, Entrepreneurship

A number of researchers submitted proposals to the Israel Innovation Authority (IIA) today under the IIA's program to fast track Covid-19 related research.

Key Points: 
  • A number of researchers submitted proposals to the Israel Innovation Authority (IIA) today under the IIA's program to fast track Covid-19 related research.
  • "We are reaching out to industry to help bring these ideas to fruition," said Dr. Itzik Goldwaser, CEO of Yissum, the technology transfer company of the Hebrew University.
  • "Among the early stage technologies currently being developed are creative ideas spanning drug discovery, MedTech and medical equipment as well as systems to better diagnose and treat coronavirus.
  • Founded in 1964, it serves as a bridge between cutting-edge academic research and a global community of entrepreneurs, investors, and industry.

Yissum Wins Bid to Host Largest International Technology Transfer Conference in 2019

Retrieved on: 
Tuesday, September 3, 2019
Geography of Asia, Western Asia, Continents, Hebrew University of Jerusalem, Mount Scopus, Israel, Jérusalem, Yissum Research Development Company of the Hebrew University

JERUSALEM, Sept. 3, 2019 /PRNewswire/ -- Yissum, the technology transfer company of the Hebrew University, today announced its selection as the host of AUTM ASIA 2019 , the largest international conference for technology transfer experts and related professionals.

Key Points: 
  • JERUSALEM, Sept. 3, 2019 /PRNewswire/ -- Yissum, the technology transfer company of the Hebrew University, today announced its selection as the host of AUTM ASIA 2019 , the largest international conference for technology transfer experts and related professionals.
  • The conference, which will be co-hosted by the Israel Technology Transfer Network (ITTN) will take place in Jerusalem, Israel on November 4-7, 2019, bringing together hundreds of academics, government and industry experts from across the globe to discuss the most important and current issues in Technology Transfer.
  • The announcement of the conference coincides with the publication of ITTN's 2018 annual report showing the collective impact of the Technology Transfer sector in Israel.
  • In 2018, Israeli tech transfer organizations (TTOs) evaluated 1,000 new innovations and filed over 620 new patents.

Hebrew University's NEXUS:ISRAEL Summit To Showcase Israel's Tech and Science Innovations

Retrieved on: 
Tuesday, April 16, 2019
Places, Geography of Asia, Cities in Asia, Hebrew University of Jerusalem, Mount Scopus, Jérusalem, Hebrew language, Yissum Research Development Company of the Hebrew University

The conference is organized by the Hebrew University of Jerusalem, Israel's top-ranked academic institution and a leading generator of technology and science startups that partner with international companies.

Key Points: 
  • The conference is organized by the Hebrew University of Jerusalem, Israel's top-ranked academic institution and a leading generator of technology and science startups that partner with international companies.
  • In an interactive afternoon session, some of Hebrew University's most prolific innovators in 3D printing, food production, bioengineering and more will present emerging technologies.
  • The session will be led by Yaron Daniely, CEO of Yissum, Hebrew University's technology transfer arm.
  • AFHU provides supporters, Hebrew University alumni, and the general public with stimulating programs and events and organizes missions to Israel.

Yissum Expands Global Reach: Establishes Strategic Partnerships in the United States, South America and China

Retrieved on: 
Wednesday, January 23, 2019
Articles, Hebrew University of Jerusalem, Mount Scopus, Technology transfer, Innovation

The new centers in Paraguay and China plan to advance technologies from Yissum's diverse portfolio of research projects and technologies throughout their respective regions.

Key Points: 
  • The new centers in Paraguay and China plan to advance technologies from Yissum's diverse portfolio of research projects and technologies throughout their respective regions.
  • In Paraguay, Yissum has partnered with HC Innovations to foster innovation and commercialization activities throughout South America.
  • "Yissum is focused on bringing the best of Hebrew University innovation to the global markets where they are most needed and valued.
  • For further information please visit www.yissum.co.il
    Contact: Estee Yaari, Media Relations, Yissum, The Technology Transfer Company of The Hebrew University, [email protected]
    View original content to download multimedia: http://www.prnewswire.com/news-releases/yissum-expands-global-reach-esta...

Yissum Announces New Platform for 3D Printing of Personalized Medicine

Retrieved on: 
Tuesday, November 6, 2018
Emerging technologies, Industrial design, Industrial processes, Hebrew University of Jerusalem, Mount Scopus, 3D printing, Printing, Design, Technology, Economy

JERUSALEM, Nov. 6, 2018 /PRNewswire/ --Yissum, the Technology Transfer Company of The Hebrew University announced a novel technology for the 3D printing of drug capsules.

Key Points: 
  • JERUSALEM, Nov. 6, 2018 /PRNewswire/ --Yissum, the Technology Transfer Company of The Hebrew University announced a novel technology for the 3D printing of drug capsules.
  • The technology will be presented at the 2nd annual conference, 3d Printing and Beyond , November 7, 2018, at the Hebrew University in Jerusalem.
  • This approach enables printing customized and personalized medications out of hydrogel objects which can expand, change shape, and activate on a delayed schedule.
  • 3D Printing and Beyond is organized by Prof. Shlomo Magdassi and Dr. Michael Layani of the 3D and Functional Printing Center at the Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem.

Yissum Launches NanoTech Fund

Retrieved on: 
Tuesday, October 9, 2018
Hebrew University of Jerusalem, Mount Scopus, Nanotechnology, Technology transfer, Technological change, Jérusalem, Yissum Research Development Company of the Hebrew University

JERUSALEM, Oct. 9, 2018 /PRNewswire/ -- Yissum, The Technology Transfer Company of The Hebrew University of Jerusalem, announced today the launch of its new NanoTech Fund which will focus exclusively on promising innovations emerging from Hebrew University's elite nanotech research.

Key Points: 
  • JERUSALEM, Oct. 9, 2018 /PRNewswire/ -- Yissum, The Technology Transfer Company of The Hebrew University of Jerusalem, announced today the launch of its new NanoTech Fund which will focus exclusively on promising innovations emerging from Hebrew University's elite nanotech research.
  • The NanoTech Fund will focus on smart materials and nanotechnologies, funding deep technologies offering integrated solutions in the areas of 3D printing, quantum science, and renewable energy.
  • "Yissum's NanoTech fund is uniquely positioned to invest in the most innovative smart materials technologies created by Hebrew University researchers," said Dr. Yaron Daniely, CEO and President of Yissum.
  • Yissum's NanoTech fund is the third investment vehicle created by Yissum in the lastsix years, with more than $50M raised by these funds to date.

NewStem Announces $4 million Seed Investment

Retrieved on: 
Monday, July 16, 2018
Geography of Asia, Religion, Hebrew University of Jerusalem, Mount Scopus, Amarna letters, Cision, Jérusalem

JERUSALEM, July 16, 2018 /PRNewswire/ -- NewStem Ltd., a Jerusalem-based biotech with a novel precision-medicine technology that can increase chemotherapy's effectiveness, today announced a $4 million seed financing from a publicly-traded US-based company to be named NovelStem International Corp. NewStem is a spinoff of Yissum, The Technology Transfer Company of The Hebrew University.

Key Points: 
  • JERUSALEM, July 16, 2018 /PRNewswire/ -- NewStem Ltd., a Jerusalem-based biotech with a novel precision-medicine technology that can increase chemotherapy's effectiveness, today announced a $4 million seed financing from a publicly-traded US-based company to be named NovelStem International Corp. NewStem is a spinoff of Yissum, The Technology Transfer Company of The Hebrew University.
  • NewStem CEO, Ayelet Dilion-Mashiah, said, "We are pleased to have secured a commitment for $4 million and a solid long-term partner through this investment.
  • This investment provides strong support for NewStem's goal of revolutionizing the treatment of cancer through personalized, patient-centered care."
  • Prior to joining NewStem in 2016, she served as CEO of BioMAS from 2011 to 2016.